LPHN3 and attention-deficit/hyperactivity disorder: Interaction with maternal stress during pregnancy

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 53, Issue 8, 2012, Pages 892-902

  Choudhry, Zia ^a,b   Sengupta, Sarojini M ^a,b   Grizenko, Natalie ^a,b   Fortier, Marie Eve ^a,b   Thakur, Geeta A ^a,b   Bellingham, Johanne ^a   Joober, Ridha ^a,b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

ADHD; environmental factors; genetic association; GXE; LPHN3; maternal stress

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LPHN3 PROTEIN, HUMAN; RECEPTOR;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; FEMALE; GENETIC ASSOCIATION; GENETICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MALE; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PSYCHOLOGICAL ASPECT; SINGLE NUCLEOTIDE POLYMORPHISM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE;

EID: 84863831504     PISSN: 00219630     EISSN: 14697610     Source Type: Journal    
DOI: 10.1111/j.1469-7610.2012.02551.x     Document Type: Article

References (69)

1. Achenbach, T.M., (1991). Manual for the Child Behavioral Checklist/4-18 and 1991 Profile. Burlington, VT: University of Vermont Department of Psychiatry.
2. Aman, C.J., Roberts, R.J. Jr, &, Pennington, B.F., (1998). A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: Frontal lobe versus right parietal lobe theories. Developmental Psychology, 34, 956-969.
3. Arcos-Burgos, M., Jain, M., Acosta, M.T., Shively, S., Stanescu, H., Wallis, D., ⋯, Muenke, M,. (2010). A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Molecular Psychiatry, 15, 1053-1066.
4. Arnsten, A.F., (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: An important role for prefrontal cortex dysfunction. CNS Drugs, 23 (Suppl. 1), 33-41.
5. Arnsten, A.F., &, Pliszka, S.R., (2011). Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacology Biochemistry and Behavior, 99, 211-216.
6. Banaschewski, T., Becker, K., Scherag, S., Franke, B., &, Coghill, D., (2010). Molecular genetics of attention-deficit/hyperactivity disorder: An overview. European Child & Adolescent Psychiatry, 19, 237-257.
7. Bhutta, A.T., Cleves, M.A., Casey, P.H., Cradock, M.M., &, Anand, K.J., (2002). Cognitive and behavioral outcomes of school-aged children who were born preterm: A meta-analysis. The Journal of the American Medical Association, 288, 728-737.
8. Biederman, J., &, Faraone, S.V., (2005). Attention-deficit hyperactivity disorder. Lancet, 366, 237-248.
9. Biederman, J., &, Spencer, T., (2002). Methylphenidate in treatment of adults with attention-deficit/hyperactivity disorder. Journal of Attention Disorders, 6 (Suppl. 1), S101-S107.
10. Bin, S.H., Ruan, Y., Xu, Z.C., &, Yokota, H., (2002). Involvement of the calcium-independent receptor for alpha-latrotoxin in brain ischemia. Brain Research Molecular Brain Research, 104, 246-249.
11. Bronfenbrenner, U., &, Ceci, S.J., (1994). Nature-nurture reconceptualized in developmental perspective: A bioecological model. Psychological Review, 101, 568-586.
12. Brose, N., Rosenmund, C., &, Rettig, J., (2000). Regulation of transmitter release by Unc-13 and its homologues. Current Opinion in Neurobiology, 10, 303-311.
13. Conners, C.K., (1994). The Conners continuous performance test. Toronto, Canada: Multi-Health Systems, Inc.
14. Conners, C.K., Sitarenios, G., Parker, J.D., &, Epstein, J.N., (1998a). Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): Factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology, 26, 279-291.
15. Conners, C.K., Sitarenios, G., Parker, J.D., &, Epstein, J.N., (1998b). The revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology, 26, 257-268.
16. Curtis, D., &, Sham, P.C., (1995). A note on the application of the transmission disequilibrium test when a parent is missing. The American Journal of Human Genetics, 56, 811-812.
17. Davletov, B.A., Meunier, F.A., Ashton, A.C., Matsushita, H., Hirst, W.D., Lelianova, V.G., ⋯, Ushkaryov, Y.A., (1998). Vesicle exocytosis stimulated by alpha-latrotoxin is mediated by latrophilin and requires both external and stored Ca2+. The EMBO Journal, 17, 3909-3920.
18. Del, C.N., Chamberlain, S.R., Sahakian, B.J., &, Robbins, T.W., (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological Psychiatry, 69, e145-e157.
19. Ehrich, M., Bocker, S., &, van den Boom, D., (2005). Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS. Nucleic Acids Research, 33, e38.
20. Faraone, S.V., Perlis, R.H., Doyle, A.E., Smoller, J.W., Goralnick, J.J., &, Holmgren, M.A., (2005). Molecular genetics of attention-deficit/ hyperactivity disorder. Biological Psychiatry, 57, 1313-1323.
21. Faraone, S.V., Sergeant, J., Gillberg, C., &, Biederman, J., (2003). The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry, 2, 104-113.
22. Franke, B., Neale, B.M., &, Faraone, S.V., (2009). Genome-wide association studies in ADHD. Human Genetics, 126, 13-50.
23. Fredriksson, R., Lagerstrom, M.C., Lundin, L.G., &, Schioth, H.B., (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Molecular Pharmacology, 63, 1256-1272.
24. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., ⋯, Altshuler, D,. (2002). The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
25. Grizenko, N., Kovacina, B., Amor, L.B., Schwartz, G., Ter-Stepanian, M., &, Joober, R., (2006). Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 47-53.
26. Gruber, R., Grizenko, N., Schwartz, G., Bellingham, J., Guzman, R., &, Joober, R., (2007). Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep, 30, 1003-1009.
27. Haldar, T., &, Ghosh, S., (2011). Power comparison between population-based case-control studies and family-based transmission- disequilibrium tests: An empirical study. Indian Journal of Human Genetics, 17, S27-S31.
28. Heaton, R.k., Chelune, G.J., Talley, J.L., Kay, G.G., &, Curtiss, G., (1993). The Wisconsin Card Sorting Test Manual-Revised and expanded. Odessa, Florida: Psychological Assessment Resources.
29. Jain, M., Velez, J.I., Acosta, M.T., Palacio, L.G., Balog, J., &, Roessler, E, ⋯, Muenke, M,. (2011). A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Molecular Psychiatry, [Epub ahead of print].
30. Jensen, A.R., (1981). Raising the IQ: The Ramsey and Haskins study. Intelligence, 5, 21-40.
31. Kebir, O., Tabbane, K., Sengupta, S., &, Joober, R., (2009). Candidate genes and neuropsychological phenotypes in children with ADHD: Review of association studies. Journal of Psychiatry & Neuroscience, 34, 88-101.
32. Knopik, V.S., Sparrow, E.P., Madden, P.A., Bucholz, K.K., Hudziak, J.J., Reich, W., ⋯, Heath, A.C., (2005). Contributions of parental alcoholism, prenatal substance exposure, and genetic transmission to child ADHD risk: A female twin study. Psychological Medicine, 35, 625-635.
33. Konrad, K., &, Eickhoff, S.B., (2010). Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Human Brain Mapping, 31, 904-916.
34. Krause, K.H., Dresel, S.H., Krause, J., Kung, H.F., &, Tatsch, K., (2000). Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neuroscience Letters, 285, 107-110.
35. Kreienkamp, H.J., Soltau, M., Richter, D., &, Bockers, T., (2002). Interaction of G-protein-coupled receptors with synaptic scaffolding proteins. Biochemical Society Transactions, 30, 464-468.
36. Kreienkamp, H.J., Zitzer, H., Gundelfinger, E.D., Richter, D., &, Bockers, T.M., (2000). The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins. Journal of Biological Chemistry, 275, 32387-32390.
37. Kuntsi, J., Rijsdijk, F., Ronald, A., Asherson, P., &, Plomin, R., (2005). Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biological Psychiatry, 57, 647-654.
38. Laird, N.M., Horvath, S., &, Xu, X., (2000). Implementing a unified approach to family-based tests of association. Genetic Epidemiology, 19, S36-S42.
39. Langley, K., Holmans, P.A., van den Bree, M.B., &, Thapar, A., (2007). Effects of low birth weight, maternal smoking in pregnancy and social class on the phenotypic manifestation of attention deficit hyperactivity disorder and associated antisocial behaviour: Investigation in a clinical sample. BioMed Central Psychiatry, 7, 26.
40. Langley, K., Rice, F., van den Bree, M.B., &, Thapar, A., (2005). Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatrica, 57, 359-371.
41. Lasky-Su, J., Neale, B.M., Franke, B., Anney, R.J., Zhou, K., Maller, J.B., ⋯, Faraone, S.V., (2008). Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B, 1345-1354.
42. Lopez de, M.R., &, Sanchez-Pernaute, R., (2010). Regulation of corticostriatal synaptic plasticity by G protein-coupled receptors. CNS & Neurological Disorders-Drug Targets, 9, 601-615.
43. Madras, B.K., Miller, G.M., &, Fischman, A.J., (2005). The dopamine transporter and attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, 1397-1409.
44. Makris, N., Biederman, J., Monuteaux, M.C., &, Seidman, L.J., (2009). Towards conceptualizing a neural systems-based anatomy of attention-deficit/ hyperactivity disorder. Developmental Neuroscience, 31, 36-49.
45. McNeil, T.F., Cantor-Graae, E., &, Sjostrom, K., (1994). Obstetric complications as antecedents of schizophrenia: Empirical effects of using different obstetric complication scales. Journal of Psychiatric Research, 28, 519-530.
46. Mick, E., Todorov, A., Smalley, S., Hu, X., Loo, S., Todd, R.D., ⋯, Faraone, S.V., (2010). Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 898-905.
47. Neale, B.M., Medland, S., Ripke, S., Anney, R.J., Asherson, P., Buitelaar, J., ⋯, Biederman, J,. (2010a). Case-control genome-wide association study of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 906-920.
48. Neale, B.M., Medland, S.E., Ripke, S., Asherson, P., Franke, B., Lesch, K.P., ⋯, Nelson, S., (2010b). Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 884-897.
49. Ogdie, M.N., Macphie, I.L., Minassian, S.L., Yang, M., Fisher, S.E., Francks, C., ⋯, Smalley, S.L., (2003). A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: Suggestive linkage on 17p11. The American Journal of Human Genetics, 72, 1268-1279.
50. Owen, M.J., O'Donovan, M.C., Thapar, A., &, Craddock, N., (2011). Neurodevelopmental hypothesis of schizophrenia. The British Journal of Psychiatry, 198, 173-175.
51. Petrides, M., &, Milner, B., (1982). Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man. Neuropsychologia, 20, 249-262.
52. Rahman, M.A., Ashton, A.C., Meunier, F.A., Davletov, B.A., Dolly, J.O., &, Ushkaryov, Y.A., (1999). Norepinephrine exocytosis stimulated by alpha-latrotoxin requires both external and stored Ca2+ and is mediated by latrophilin, G proteins and phospholipase C. Philosophical Transactions of the Royal Society: Biological Sciences, 354, 379-386.
53. Ribases, M., Ramos-Quiroga, J.A., Sanchez-Mora, C., Bosch, R., Richarte, V., Palomar, G., ⋯, Casas, M., (2011). Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: A replication study. Gene, Brain and Behaviour, 10, 149-157.
54. Scarr, S., (1981). Race, social class, and individual differences in I.Q.: New studies of old issues. Hillsdale, NJ: Erlbaum.
55. Shaffer, D., Fisher, P., Lucas, C.P., Dulcan, M.K., &, Schwab-Stone, M.E., (2000). NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 28-38.
56. Shallice, T., (1982). Specific impairments of planning. Philosophical Transactions of the Royal Society: Biological Sciences, 298, 199-209.
57. Shaw, P., &, Rabin, C., (2009). New insights into attention-deficit/hyperactivity disorder using structural neuroimaging. Current Psychiatry Reports, 11, 393-398.
58. Sheslow, D., &, Adams, W., (1990). Wide range assessment of memory and learning: Administration manual. Wilmington, DE: Jastak.
59. Silva, J.P., Suckling, J., &, Ushkaryov, Y., (2009). Penelope's web: Using alpha-latrotoxin to untangle the mysteries of exocytosis. Journal of Neurochemistry, 111, 275-290.
60. Smalley, S.L., Kustanovich, V., Minassian, S.L., Stone, J.L., Ogdie, M.N., McGough, J.J., ⋯, Nelson, S.F., (2002). Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. The American Journal of Human Genetics, 71, 959-963.
61. Taerk, E., Grizenko, N., Ben, A.L., Lageix, P., Mbekou, V., Deguzman, R., ⋯, Joober, R,. (2004). Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. The American Journal of Human Genetics, 5, 30.
62. Thapar, A., Cooper, M., Jefferies, R., &, Stergiakouli, E., (2011). What causes attention deficit hyperactivity disorder? Archives of Disease in Childhood, 97, 260-265.
63. Thapar, A., Langley, K., O'Donovan, M., &, Owen, M., (2006). Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Molecular Psychiatry, 11, 714-720.
64. Turkheimer, E., (1991). Individual and group differences in adoption studies of IQ. Psychological Bulletin, 110, 392-405.
65. Volkow, N.D., Wang, G., Fowler, J.S., Logan, J., Gerasimov, M., Maynard, L., ⋯, Franceschi, D,. (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience, 21, RC121.
66. Wermter, A.K., Laucht, M., Schimmelmann, B.G., Banaschweski, T., Sonuga-Barke, E.J., Rietschel, M., ⋯, Becker, K,. (2010). From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders. European Child & Adolescent Psychiatry, 19, 199-210.
67. Weschler, D,. (1991). Weschler Intelligence Scale for Children- Third Edition: Manual. San Antonio, TX: Psychological Corporation.
68. Willcutt, E.G., Doyle, A.E., Nigg, J.T., Faraone, S.V., &, Pennington, B.F., (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biological Psychiatry, 57, 1336-1346.
69. Willson, J., Amliwala, K., Davis, A., Cook, A., Cuttle, M.F., Kriek, N., ⋯, Holden-Dye, L,. (2004). Latrotoxin receptor signaling engages the UNC-13-dependent vesicle-priming pathway in C. elegans. Current Biology, 14, 1374-1379.